PRospective Multiple Myeloma Impact Study
| Status: | Recruiting |
|---|---|
| Conditions: | Blood Cancer, Hematology, Hematology |
| Therapuetic Areas: | Hematology, Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/5/2018 |
| Start Date: | February 27, 2018 |
| End Date: | December 1, 2024 |
| Contact: | Lisette Stork, MSc |
| Email: | lstork@medex15.com |
| Phone: | +32479567390 |
Prospective Multicenter Study to Measure the Impact of MMprofiler on Treatment Intention in Active Multiple Myeloma Patients
This will be a prospective, case-only, study to measure the impact of MMprofiler on treatment
intention decisions in active Multiple Myeloma patients.
intention decisions in active Multiple Myeloma patients.
This will be a prospective, case-only, study to measure the impact of MMprofiler on treatment
intention decisions in active MM patients.
Eligible patients will have their tumor sample analyzed for the prognostic MMprofiler SKY92,
several cytogenetic markers, gene expression markers, and gene expression clusters.
A total of 250 patients will be enrolled from up to 7 US centers. Patients will be followed 5
years after diagnosis.
intention decisions in active MM patients.
Eligible patients will have their tumor sample analyzed for the prognostic MMprofiler SKY92,
several cytogenetic markers, gene expression markers, and gene expression clusters.
A total of 250 patients will be enrolled from up to 7 US centers. Patients will be followed 5
years after diagnosis.
Inclusion Criteria:
- Potentially active and active multiple myeloma according to IMWG criteria
- Candidates for systemic treatment
Exclusion Criteria:
- ECOG Performance Status > 3
- Tumor sample that fails QA or QC criteria for MMprofiler
We found this trial at
6
sites
Medical College of Wisconsin The Medical College (MCW) of Wisconsin is a major national research...
Click here to add this to my saved trials
Click here to add this to my saved trials
30 Prospect Ave
Hackensack, New Jersey 07601
Hackensack, New Jersey 07601
(201) 996-2000
Principal Investigator: David Siegel, MD
Hackensack University Medical Center Hackensack University Medical Center, part of the Hackensack University Health Network,...
Click here to add this to my saved trials
Columbia University Medical Center Situated on a 20-acre campus in Northern Manhattan and accounting for...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials